In Brief This Week: Dow AgroSciences; Chromatin; OriGene Technologies; Jubliant Biosys; Pacific Biosciences; CamStar Systems | GenomeWeb

NEW YORK (GenomeWeb News) – Dow AgroSciences and Chromatin announced this week that they have struck a pair of agreements. The first provides Dow AgroSciences, a subsidiary of Dow Chemical Company, the rights to Chromatin's "mini-chromosome" genetic elements for delivering specific traits into plant cells. The second establishes an exclusive research and license agreement to combine Dow's EXZACT Precision genome-modification technology with mini-chromosomes, creating a technology platform to develop next-generation traits in corn, soybeans, and canola.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.